top of page
The Twilight of Aspirin: A Meta-Analysis of P2Y12 Inhibitor Monotherapy vs. Dual Antiplatelet Therapy (DAPT) Following Third-Generation Drug-Eluting Stent Implantation.
Original Research | 2026 | Volume 2 | Issue 1 | Page 01-14 Dr. Ibrahim Kureshy, Lecturer, Cardiology, DMCH-UAE Abstract For decades, dual antiplatelet therapy (DAPT)—combining aspirin with a P2Y_{12} inhibitor—has been the gold standard for preventing thrombotic complications following percutaneous coronary intervention (PCI). However, the advent of third-generation drug-eluting stents (DES) with thinner struts and biocompatible polymers has significantly reduced stent thromb
The "24/7" Cardiologist: Integration of Continuous Wearable Sensor Data into AI-Driven Heart Failure Predictive Models.
Original Research | 2026 | Volume 2 | Issue 1 | Page 25-33 Dr. Amin Sekha Hassain, Professor, Cardiology, Dubai Medical College, UAE Abstract The management of Chronic Heart Failure (CHF) is currently transitioning from intermittent, clinic-based snapshots to a model of Continuous Physiological Surveillance . In the 2024–2026 digital health landscape, the proliferation of consumer-grade and medical-grade wearables (smartwatches, rings, and patches) has created a vast reservoi
Intravascular Ultrasound (IVUS) versus Optical Coherence Tomography (OCT) in the Era of High-Potency Statins: A Comparative Analysis of Plaque Morphological Assessment.
Original Research | 2025 | Volume 1 | Issue 1 | Page 70-79 Dr. Ibrahim Kureshy, Lecturer, Cardiology, DMCH-UAE Dr. Rabia Fatima, Lecturer, Cardiology, DMCH-UAE Abstract The clinical management of coronary artery disease has evolved from a focus on luminal diameter to a deep molecular understanding of Plaque Vulnerability. In the 2024–2026 era, the widespread use of high-potency statins, PCSK9 inhibitors, and Inclisiran has fundamentally altered the "Biological Landscape" of t
Navigating the "Prohibitive Risk" Frontier: A Contemporary Review of Mechanical Circulatory Support in Complex High-Risk Indicated Patient (CHIP) Interventions.
Original Research | 2025 | Volume 1 | Issue 1 | Page 60-69 Dr. Jambia Khatoon, Assistant Professor, Cardiology, IPGMER, Kolkata Abstract The definition of "revascularization candidates" has undergone a radical expansion, moving into the CHIP (Complex High-Risk Indicated Patient) domain. This population is defined by a "Triple Threat" of complex coronary anatomy (CTO, multivessel disease, severe calcification), severely depressed left ventricular function (LVEF < 35%), and pro
Deep Learning-Enhanced ECG Analysis for the Prediction of Occult Atrial Fibrillation: A Multi-Center Prospective Validation Study
Original Research | 2025 | Volume 1 | Issue 1 | Page 50-59 Dr. Sayama Prasad, Professor, Cardiology, GMC-Asam Dr. Arun Sharma, Professor, Cardiology, GMC-Jalgaow Abstract Background: Atrial Fibrillation (AFib) remains a leading cause of cryptogenic stroke due to its often paroxysmal and asymptomatic ("occult") nature. Traditional screening relies on symptomatic presentation or prolonged Holter monitoring, which often fails to capture intermittent episodes. This study evaluate
bottom of page